AI assistant
Sending…
RESMED INC — Director's Dealing 2015
Nov 23, 2015
30071_dirs_2015-11-23_f43ca375-f1bd-4596-ab29-b2341b36f6b2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2015-11-19
Reporting Person: Douglas Robert Andrew (President and COO ResMed Inc.)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-11-19 | ResMed Common Stock Options | $58.24 | A | 150098 | Acquired | 2022-11-19 | ResMed Commmon Stock (150098) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 31304 | Direct |
| ResMed Common Stock | 76611.3415 | Indirect |
Footnotes
F1: Represents date options first become exercisable. Options vest 1/3 annually each November 11, 2016, 2017 and 2018.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29